Anticancer Drugs Course
This Anticancer Drugs Course equips oncology professionals with practical knowledge on first-line systemic treatments for EGFR-mutated NSCLC, covering targeted therapies, chemo-immunotherapy, and chemotherapy. Learners master drug mechanisms, dosing, toxicity management, resistance strategies, second-line options, monitoring, and patient communication for evidence-based decisions and better patient outcomes.

from 4 to 360h flexible workload
valid certificate in your country
What will I learn?
Gain a practical overview of first-line treatments for EGFR-mutated NSCLC, including targeted therapy, chemo-immunotherapy, and chemotherapy. Master drug mechanisms, dosing schedules, toxicity profiles, prevention and management, resistance mechanisms, second-line therapies, monitoring protocols, and effective patient communication for confident clinical decisions.
Elevify advantages
Develop skills
- Select EGFR TKI first-line regimens based on latest trial evidence.
- Plan imaging, re-biopsy, and liquid biopsy for resistance assessment.
- Match resistance to targeted therapy, chemo, or trials for second-line.
- Prevent and manage EGFR TKI rash, diarrhea, ILD, and cytopenias.
- Counsel patients clearly on goals, side effects, and progression plans.
Suggested summary
Before starting, you can change the chapters and workload. Choose which chapter to start with. Add or remove chapters. Increase or decrease the course workload.What our students say
FAQs
Who is Elevify? How does it work?
Do the courses have certificates?
Are the courses free?
What is the course workload?
What are the courses like?
How do the courses work?
What is the duration of the courses?
What is the cost or price of the courses?
What is an EAD or online course and how does it work?
PDF Course